Total ginsenosides synergize with ulinastatin against septic acute lung injury and acute respiratory distress syndrome
- PMID: 26261640
- PMCID: PMC4525974
Total ginsenosides synergize with ulinastatin against septic acute lung injury and acute respiratory distress syndrome
Abstract
Total ginsenosides synergize with ulinastatin (UTI) against septic acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). We randomly divided 80 cases of severe sepsis-induced ALI and ARDS into a UTI group and a ginsenosides (GS)+UTI group. Continuous electrocardiac monitoring of pulse, respiratory rate, blood pressure, and heart rate; invasive hemodynamic monitoring; ventilator-assisted breathing and circulation support; and anti-infection as well as UTI treatment were given in the UTI group with GS treatment added for 7 consecutive days in the GS+UTI group. The indicators of pulmonary vascular permeability, pulmonary circulation, blood gases, and hemodynamics as well as APACHE II and ALI scores were detected on days 1, 3, and 7. The ALI score in the GS+UTI group was significantly decreased (P < 0.05) compared with that of the UTI group, and the indicators of pulmonary capillary permeability such as pulmonary vascular permeability index, extravascular lung water index, and oxygenation index, in the GS+UTI group improved significantly more than that of the UTI group. The indicators of hemodynamics and pulmonary circulation such as cardiac index, intrathoracic blood volume index, and central venous pressure improved significantly (P < 0.05), and the APACHE II score in the GS+UTI group was lower than that of the UTI group. GS can effectively collaborate with UTI against ALI and/or ARDS.
Keywords: ALI; ARDS; Ulinastatin; ginsenoside; sepsis; systemic inflammatory response syndrome.
Similar articles
-
A comparative analysis of sivelestat sodium hydrate and ulinastatin combination therapy in the treatment of sepsis with acute respiratory distress syndrome.BMC Pulm Med. 2024 Jun 17;24(1):283. doi: 10.1186/s12890-024-03083-w. BMC Pulm Med. 2024. PMID: 38886709 Free PMC article.
-
Effect of Ulinastatin, a human urinary trypsin inhibitor, on the oleic acid-induced acute lung injury in rats via the inhibition of activated leukocytes.Injury. 2005 Mar;36(3):387-94. doi: 10.1016/j.injury.2004.06.018. Injury. 2005. PMID: 15710155
-
Effects of hydroxyethyl starch resuscitation on extravascular lung water and pulmonary permeability in sepsis-related acute respiratory distress syndrome.Crit Care Med. 2009 Jun;37(6):1948-55. doi: 10.1097/CCM.0b013e3181a00268. Crit Care Med. 2009. PMID: 19384203
-
Could Heme Oxygenase-1 Be a New Target for Therapeutic Intervention in Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome?Front Cell Infect Microbiol. 2018 May 16;8:161. doi: 10.3389/fcimb.2018.00161. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 29868517 Free PMC article. Review.
-
From neurogenic pulmonary edema to fat embolism syndrome: a brief review of experimental and clinical investigations of acute lung injury and acute respiratory distress syndrome.Chin J Physiol. 2009 Nov 30;52(5 Suppl):339-44. doi: 10.4077/cjp.2009.amh036. Chin J Physiol. 2009. PMID: 20359124 Review.
Cited by
-
A comparative analysis of sivelestat sodium hydrate and ulinastatin combination therapy in the treatment of sepsis with acute respiratory distress syndrome.BMC Pulm Med. 2024 Jun 17;24(1):283. doi: 10.1186/s12890-024-03083-w. BMC Pulm Med. 2024. PMID: 38886709 Free PMC article.
-
Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients?Biomed Pharmacother. 2021 Feb;134:111143. doi: 10.1016/j.biopha.2020.111143. Epub 2020 Dec 16. Biomed Pharmacother. 2021. PMID: 33360048 Free PMC article. Review.
-
Ulinastatin protects the lungs of COPD rats through the HMGB1/TLR4 signaling pathway.Oncol Lett. 2018 Sep;16(3):4057-4063. doi: 10.3892/ol.2018.9123. Epub 2018 Jul 11. Oncol Lett. 2018. PMID: 30128028 Free PMC article.
-
Effects of ulinastatin combined with mechanical ventilation on oxygen metabolism, inflammation and stress response and antioxidant capacity of ARDS.Exp Ther Med. 2018 Jun;15(6):4665-4670. doi: 10.3892/etm.2018.6012. Epub 2018 Mar 30. Exp Ther Med. 2018. PMID: 29805484 Free PMC article.
-
Therapeutic Risk and Benefits of Concomitantly Using Herbal Medicines and Conventional Medicines: From the Perspectives of Evidence Based on Randomized Controlled Trials and Clinical Risk Management.Evid Based Complement Alternat Med. 2017;2017:9296404. doi: 10.1155/2017/9296404. Epub 2017 Apr 11. Evid Based Complement Alternat Med. 2017. PMID: 28491115 Free PMC article. Review.
References
-
- Dellinqer RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2008;34:17–60. - PMC - PubMed
-
- Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin definition. ARDS definition task force. JAMA. 2012;307:2526–2533. - PubMed
-
- Ito K, Mizutani A, Kira S, Mori M, Iwasaka H, Noguchi T. Effect of ulinastatin, a human urinary trypsin inhibitor, on the oleic acid-induced acute lung injury in rats via the inhibition of acticated leakocytes. Injury. 2005;36:387–394. - PubMed
-
- Cao ZL, Okazaki Y, Naito K, Ueno T, Natsuaki M, Itoh T. Ulinastatin attenuates reperfusion injury in isolated blood-perfused rabbit heart. Ann Thorac Surg. 2000;69:1121–1126. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources